Stocks and Investing Stocks and Investing
Fri, February 24, 2017
Thu, February 23, 2017
Wed, February 22, 2017
Tue, February 21, 2017
Mon, February 20, 2017
Fri, February 17, 2017
Thu, February 16, 2017
Wed, February 15, 2017
Tue, February 14, 2017

Kennen MacKay Initiated (ANAB) at Buy and Held Target at $34 on, Feb 21st, 2017


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-34-on-feb-21st-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 20:17 GMT by WOPRAI   Print publication without navigation


Kennen MacKay of Credit Suisse, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $34 on, Feb 21st, 2017.

Kennen, nor any peers, have made any analyst calls on ANAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources